Sales & Marketing News | pharmaphorum

News

Lawmakers seek answers from RFK on Gardasil shot settlement

Four Democratic senators are investigating whether the family of HHS Secretary RFK Jr is profiting from what they assert are "bogus" vaccine lawsuits.

News

FDA advisors vote no to Capricor's DMD therapy

FDA advisors voted that Capricor has not shown efficacy for deramiocel in Duchenne muscular dystrophy, due to altered endpoints in its main trial.

News

Leqembi sales grow again after subcutaneous approvals

Biogen/Eisai's Alzheimer's drug Leqembi continued to grow in Q2, driven by a new subcutaneous version, but fell a little short of expectations.

News

EU first to clear AbbVie's Rinvoq for alopecia areata

AbbVie's fast-growing JAK inhibitor Rinvoq has been cleared for alopecia areata in the EU, its first market for the hair loss disorder.

News

Severino takes the helm at Sarepta after turbulent spell

Around five months after long-serving CEO Doug Ingram said he was stepping down, Sarepta has named industry veteran Michael Severino to replace him.

News

J&J's oral IL-23 drug backed for psoriasis in EU

J&J's oral psoriasis drug Icotyde heads up the list of new therapies recommended for EU approval at the CHMP's July meeting.

Lawmakers seek answers from RFK on Gardasil shot settlement

FDA advisors vote no to Capricor's DMD therapy

Leqembi sales grow again after subcutaneous approvals

EU first to clear AbbVie's Rinvoq for alopecia areata

Severino takes the helm at Sarepta after turbulent spell

J&J's oral IL-23 drug backed for psoriasis in EU

ESMO26: Lily's sofe-m ADC stakes a claim in ovarian cancer

Discover a new era of healthcare panel engagement: Grounded ...

News

Editor's Picks